Physician profile
Jonathan R Weinstein
NPI 1528154440
$1,628.12
in general payments reported to CMS, 2019-2025
27 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $80.08 · 2021: $226 · 2022: $384 · 2023: $242 · 2024: $159 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.36 | 2019-2022 | |
| Boston Scientific Corporation | $189.15 | 2019-2025 | General - Female Sui |
| Astellas Pharma US INC | $144.34 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $136.08 | 2019-2025 | Slynd |
| Sage Therapeutics, LLC | $120.21 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $80.03 | 2019-2023 | |
| Minerva Surgical, INC | $76.85 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.58 | 2022 | |
| Organon LLC | $61.62 | 2023-2025 | Nexplanon |
| Integra Lifesciences Corporation | $44.55 | 2023-2024 | Biodoptix, Biofix, Biodrestore |
| Avanos Medical | $43.07 | 2021 | |
| Amgen INC. | $39.72 | 2022-2025 | Evenity |
| Smith+Nephew, INC. | $34.88 | 2019 | |
| Pfizer INC. | $31.32 | 2023 | |
| Therapeuticsmd, INC. | $30.54 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.47 | 2022-2023 | Adept |
| Medtronic, INC. | $27.00 | 2024 | V-Loc 180 |
| Supernus Pharmaceuticals, INC. | $20.74 | 2025 | Qelbree |
| Myovant Sciences INC. | $20.25 | 2021 | |
| Lupin INC. | $18.93 | 2020 | |
| Channel Medsystems, INC. | $18.91 | 2022 | |
| Agile Therapeutics, INC. | $17.98 | 2021 | |
| Avion Pharmaceuticals | $17.38 | 2021 | |
| Ethicon US, LLC | $16.83 | 2019 | |
| Hologic Sales and Service, LLC | $15.30 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.03 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.